Long-term analysis shows cost-effectiveness of WATCHMAN left atrial appendage closure device over warfarin and NOACs in reducing stroke risk in non-valvular atrial fibrillation patients.
from Today's Healthcare News -- ScienceDaily http://ift.tt/1V8TfHi
No comments:
Post a Comment